Daiwa Securities Group
RLAY icon

Daiwa Securities Group’s Relay Therapeutics RLAY Stock Holding History

Daiwa Securities Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-486
Closed -$4K – 1393
2025
Q4 		$4K Hold
486
– – ﹤0.01% 1257
2025
Q3 		$3K Hold
486
– – ﹤0.01% 1248
2025
Q2 		$2K Hold
486
– – ﹤0.01% 1223
2025
Q1 		$1K Hold
486
– – ﹤0.01% 1248
2024
Q4 		$2K Hold
486
– – ﹤0.01% 1228
2024
Q3 		$3K Hold
486
– – ﹤0.01% 1204
2024
Q2 		$3K Hold
486
– – ﹤0.01% 1234
2024
Q1 		$4K Hold
486
– – ﹤0.01% 1224
2023
Q4 		$5K Hold
486
– – ﹤0.01% 1206
2023
Q3 		$4K Hold
486
– – ﹤0.01% 1178
2023
Q2 		$6K Hold
486
– – ﹤0.01% 1171
2023
Q1 		$8K Hold
486
– – ﹤0.01% 1125
2022
Q4 		$7K Buy
486
+81
+20% +$1.55K ﹤0.01% 1134
2022
Q3 		$9K Hold
405
– – ﹤0.01% 1133
2022
Q2 		$7K Buy
405
+88
+28% +$1.89K ﹤0.01% 1151
2022
Q1 		$9K Hold
317
– – ﹤0.01% 1144
2021
Q4 		$10K Hold
317
– – ﹤0.01% 1152
2021
Q3 		$10K Buy
317
+148
+88% +$4.98K ﹤0.01% 1142
2021
Q2 		$6K Hold
169
– – ﹤0.01% 1066
2021
Q1 		$6K Hold
169
– – ﹤0.01% 1071
2020
Q4 		$7K Buy
+169
New +$7.64K ﹤0.01% 1036

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Daiwa Securities Group's RLAY Position: Q1 2026 in Review

Daiwa Securities Group sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 486 shares — an estimated $4K sold.

Daiwa Securities Group first reported a position in RLAY in Q4 2020 and held it in 21 quarters. The position peaked at $10K in Q4 2021. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Daiwa Securities Group reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 486 Relay Therapeutics shares in Q1 2026, an estimated $4K.
  • Daiwa Securities Group first reported a position in Relay Therapeutics in Q4 2020 and held it in 21 quarters.
  • Daiwa Securities Group's Relay Therapeutics position peaked at $10K in Q4 2021.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.